<SEC-DOCUMENT>0001140361-24-034468.txt : 20240726
<SEC-HEADER>0001140361-24-034468.hdr.sgml : 20240726
<ACCEPTANCE-DATETIME>20240726210010
ACCESSION NUMBER:		0001140361-24-034468
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240724
FILED AS OF DATE:		20240726
DATE AS OF CHANGE:		20240726

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tade Brad L.
		CENTRAL INDEX KEY:			0002030561
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36728
		FILM NUMBER:		241148572

	MAIL ADDRESS:	
		STREET 1:		5800 PARK OF COMMERCE BLVD., NW
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADMA BIOLOGICS, INC.
		CENTRAL INDEX KEY:			0001368514
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				562590442
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446
		BUSINESS PHONE:		(201) 478-5552

	MAIL ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	R&R ACQUISITION VI, INC
		DATE OF NAME CHANGE:	20060707
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2024-07-24</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001368514</issuerCik>
        <issuerName>ADMA BIOLOGICS, INC.</issuerName>
        <issuerTradingSymbol>ADMA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002030561</rptOwnerCik>
            <rptOwnerName>Tade Brad L.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADMA BIOLOGICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>5800 PARK OF COMMERCE BLVD. NW</rptOwnerStreet2>
            <rptOwnerCity>BOCA RATON</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>33487</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>true</isOfficer>
            <officerTitle>CFO and Treasurer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>17033</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>75000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
                <footnoteId id="F3"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>50000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Includes shares acquired in open market purchases and pursuant to the vesting of restricted stock units (&quot;RSUs&quot;).</footnote>
        <footnote id="F2">On June 26, 2023, the Issuer granted the reporting person 100,000 RSUs, 75,000 of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting. Of the 25,000 RSUs that vested on June 26, 2024, 9,838 shares were withheld by the Issuer to satisfy mandatory tax withholding requirements.</footnote>
        <footnote id="F3">On February 26, 2024, the Issuer granted the reporting person 50,000 RSUs, all of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting.</footnote>
    </footnotes>

    <remarks>Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Brad L. Tade, by Adam S. Grossman as attorney-in-fact</signatureName>
        <signatureDate>2024-07-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ef20033115_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 24.6.1.5240
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">

  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 24</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <hr noshade="noshade" align="" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; color: #000000;"><u></u></div>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">LIMITED POWER OF ATTORNEY</div>
      <div style="text-align: center; font-weight: bold;">FOR SECTION 16(a) REPORTING</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Adam S. Grossman, President and
        Chief Executive Officer, and Michael A. Goldstein, Senior Director, General Counsel, of ADMA Biologics, Inc. (the &#8220;Company&#8221;), and each of them, as the undersigned&#8217;s true and lawful attorney-in-fact (the &#8220;Attorney-in Fact&#8221;), with full power of
        substitution and resubstitution, with the power to act alone for the undersigned and in the undersigned&#8217;s name, place and stead, in any and all capacities to:</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; prepare, execute and submit to the Securities and Exchange Commission (&#8220;SEC&#8221;), any national securities exchange and the Company any
        and all reports (including any amendment thereto) of the undersigned required or considered advisable under Section 16(a) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), and the rules and regulations thereunder, with respect to the
        equity securities of the Company, including Form 3 (Initial Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership), and Form 5 (Annual Statement of Changes in Beneficial Ownership); and</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; seek or obtain, as the undersigned&#8217;s representative and on the undersigned&#8217;s behalf, information regarding transactions in the
        Company&#8217;s equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the
        Attorney-in-Fact.</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The undersigned acknowledges that:</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; this Limited Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act at his discretion on information
        provided to such Attorney-in-Fact without independent verification of such information;</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any documents prepared and/or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Limited Power of
        Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his discretion, deems necessary or desirable;</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned&#8217;s responsibility to comply with the
        requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned&#8217;s
        obligations under Section 16 of the Exchange Act, including, without, limitation, the reporting requirements under Section 16(a) of the Exchange Act.</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing
        requisite, necessary or convenient to be done in connection with the foregoing, as fully, to all intents and purposes, as the undersigned might or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his substitute
        or substitutes, shall lawfully do or cause to be done by authority of this Limited Power of Attorney.</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4
        or 5 with respect to the undersigned&#8217;s holdings of and transactions in equity securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact.</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Limited Power of Attorney shall be governed by and construed in accordance the laws of the State of Delaware without regard
        to the laws that might otherwise govern under applicable principles of conflicts of laws thereof.</div>
      <div style="font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of July 25, 2024.</div>
      <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 40%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 60%;">Signature:&#160;&#160;&#160; <u>/s/ Brad L. Tade</u></td>
              </tr>
              <tr>
                <td style="width: 40%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 60%;">Print Name: Brad L. Tade</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
